These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22781098)

  • 1. Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
    Beck BB; Baasner A; Buescher A; Habbig S; Reintjes N; Kemper MJ; Sikora P; Mache C; Pohl M; Stahl M; Toenshoff B; Pape L; Fehrenbach H; Jacob DE; Grohe B; Wolf MT; Nürnberg G; Yigit G; Salido EC; Hoppe B
    Eur J Hum Genet; 2013 Feb; 21(2):162-72. PubMed ID: 22781098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.
    Pelle A; Cuccurullo A; Mancini C; Sebastiano R; Stallone G; Negrisolo S; Benetti E; Peruzzi L; Petrarulo M; De Marchi M; Marangella M; Amoroso A; Giachino D; Mandrile G
    J Nephrol; 2017 Apr; 30(2):219-225. PubMed ID: 26946417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
    Monico CG; Rossetti S; Belostotsky R; Cogal AG; Herges RM; Seide BM; Olson JB; Bergstrahl EJ; Williams HJ; Haley WE; Frishberg Y; Milliner DS
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2289-95. PubMed ID: 21896830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in
    Bar R; Ben-Shalom E; Duvdevani M; Belostotsky R; Pollak MR; Mount DB; Bar-Gal R; Gnessin E; Tzur S; Curhan GC; Frishberg Y
    J Urol; 2021 May; 205(5):1394-1399. PubMed ID: 33350326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
    Fang X; He L; Xu G; Lin H; Xu M; Geng H
    Pediatr Nephrol; 2019 Oct; 34(10):1785-1790. PubMed ID: 31123811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOGA1 gene pathogenic variants in primary hyperoxaluria type III: Spectrum of pathogenic sequence variants, and phenotypic association.
    Abid A; Raza A; Aziz T; Khaliq S
    Hum Mutat; 2022 Dec; 43(12):1757-1779. PubMed ID: 36259736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.
    M'dimegh S; Aquaviva-Bourdain C; Omezzine A; Souche G; M'barek I; Abidi K; Gargah T; Abroug S; Bouslama A
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27561601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.
    Wang W; Liu Y; Kang L; He R; Song J; Li Y; Li J; Yang Y
    Kidney Blood Press Res; 2019; 44(4):743-753. PubMed ID: 31401635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function can be impaired in children with primary hyperoxaluria type 3.
    Allard L; Cochat P; Leclerc AL; Cachat F; Fichtner C; De Souza VC; Garcia CD; Camoin-Schweitzer MC; Macher MA; Acquaviva-Bourdain C; Bacchetta J
    Pediatr Nephrol; 2015 Oct; 30(10):1807-13. PubMed ID: 25972204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.
    Wang X; Zhao X; Wang X; Yao J; Zhang F; Lang Y; Tuffery-Giraud S; Bottillo I; Shao L
    Am J Nephrol; 2015; 42(1):78-84. PubMed ID: 26340091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.
    Williams EL; Bockenhauer D; van't Hoff WG; Johri N; Laing C; Sinha MD; Unwin R; Viljoen A; Rumsby G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3191-5. PubMed ID: 22391140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late diagnosis of primary hyperoxaluria type III.
    Richard E; Blouin JM; Harambat J; Llanas B; Bouchet S; Acquaviva C; de la Faille R
    Ann Clin Biochem; 2017 May; 54(3):406-411. PubMed ID: 27742850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
    MacDonald JR; Huang AD; Loomes KM
    FEBS Lett; 2016 May; 590(10):1467-76. PubMed ID: 27096395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite diagnosis of primary hyperoxaluria type 3.
    Greed L; Willis F; Johnstone L; Teo S; Belostotsky R; Frishberg Y; Pitt J
    Pediatr Nephrol; 2018 Aug; 33(8):1443-1446. PubMed ID: 29705963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants.
    Abid A
    Mol Biol Rep; 2021 Apr; 48(4):3841-3844. PubMed ID: 33948853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.
    Singh P; Granberg CF; Harris PC; Lieske JC; Licht JH; Weiss A; Milliner DS
    Am J Kidney Dis; 2022 Jan; 79(1):125-128. PubMed ID: 34245816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney cysts in patients with
    Patel DM; Page N; Dahl NK
    Clin Nephrol; 2023 May; 99(5):260-264. PubMed ID: 36928260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic aspects of primary hyperoxaluria: diagnostics and treatment].
    Filippova TV; Svetlichnaya DV; Rudenko VI; Alyaev YG; Shumikhina MV; Azova MM; Subbotina TI; Gadzhieva ZK; Asanov AY; Litvinova MM
    Urologiia; 2019 Dec; (5):140-143. PubMed ID: 31808650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in DHDPSL are responsible for primary hyperoxaluria type III.
    Belostotsky R; Seboun E; Idelson GH; Milliner DS; Becker-Cohen R; Rinat C; Monico CG; Feinstein S; Ben-Shalom E; Magen D; Weissman I; Charon C; Frishberg Y
    Am J Hum Genet; 2010 Sep; 87(3):392-9. PubMed ID: 20797690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
    Kanoun H; Jarraya F; Maalej B; Lahiani A; Mahfoudh H; Makni F; Hachicha J; Fakhfakh F
    BMC Nephrol; 2017 Oct; 18(1):303. PubMed ID: 28969594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.